- 8.   Where  a  certificate  is  supplemented,  modified  or  re-issued,  the  new  certificate  shall  contain  a  reference  to  the preceding certificate and its date of issue with identification of the changes.
## CHAPTER II
## MINIMUM CONTENT OF THE CERTIFICATES
- 1.  name, address and identification number of the notified body;
- 2.  name and address of the manufacturer and, if applicable, of the authorised representative;
- 3.  unique number identifying the certificate;
- 4.  if already issued, the SRN of  the manufacturer referred to in to Article 31(2);
- 5.  date of issue;
- 6.  date of expiry;
- 7.  data  needed  for  the  unambiguous  identification  of  the  device  or  devices  where  applicable  as  specified  in  Section  4 of Part I;
- 8.  if applicable, reference to any previous certificate as specified in Section 8 of Chapter I;
- 9.  reference  to  this  Regulation  and  the  relevant  Annex  in  accordance  with  which  the  conformity  assessment  has  been carried out;
- 10.  examinations  and  tests  performed,  e.g.  reference  to  relevant  CS,  harmonised  standards,  test  reports  and  audit report(s);
- 11.  if  applicable,  reference  to  the  relevant  parts  of  the  technical  documentation  or  other  certificates  required  for  the placing on the market of the device or devices covered;
- 12.  if applicable, information about the surveillance by the notified body;
- 13.  conclusions of the notified body's conformity assessment with regard to the relevant Annex;
- 14.  conditions for or limitations to the validity of  the certificate;
- 15.  legally binding signature of the notified body in accordance with the applicable national law. ANNEX XIII
## PROCEDURE FOR CUSTOM-MADE DEVICES
- 1.   For  custom-made  devices,  the  manufacturer  or  its  authorised  representative  shall  draw  up  a  statement  containing  all of  the following information:
- -  the name and address of the manufacturer, and of all manufacturing sites,
- -  if applicable, the name and address of the authorised representative,
- -  data allowing identification of the device in question,
- -  a  statement  that  the  device  is  intended  for  exclusive  use  by  a  particular  patient  or  user,  identified  by  name,  an acronym or a numerical code,
- -  the  name  of  the  person  who  made  out  the  prescription  and  who  is  authorised  by  national  law  by  virtue  of  their professional qualifications to do so, and, where applicable, the name of the health institution concerned,
- -  the specific characteristics of the product as indicated by the prescription,
- -  a  statement  that  the  device  in  question  conforms  to  the  general  safety  and  performance  requirements  set  out  in Annex I and, where applicable, indicating which general safety and performance requirements have not been fully met, together  with the grounds,
- -  where applicable, an indication that the device contains or incorporates a medicinal substance, including a human blood or plasma  derivative, or tissues or cells of human  origin, or of animal origin as referred to in Regulation (EU) No 722/2012.
- 2.   The  manufacturer  shall  undertake  to  keep  available  for  the  competent  national  authorities  documentation  that indicates  its  manufacturing  site  or  sites  and  allows  an  understanding  to  be  formed  of  the  design,  manufacture  and performance  of  the  device,  including  the  expected  performance,  so  as  to  allow  assessment  of  conformity  with  the requirements of this Regulation.
- 3.   The  manufacturer  shall  take  all  the  measures  necessary  to  ensure  that  the  manufacturing  process  produces  devices which are manufactured in accordance with the documentation referred to in Section 2.
- 4.   